Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Role of Neutrophil Extracellular Traps and their Toll-like Receptors in Insulin Resistance and Type II Diabetes
EF 2013-14
Résumé
Obesity and type 2 diabetes (T2D) are major global health concerns. Over 25 percent of Canadians are obese, and these individuals are at high risks for developing insulin resistance (IR) and T2D. Insulin resistance is a condition where the body’s cells fail to respond to the effects of insulin, a hormone responsible for reducing blood sugar levels. Over time, the condition can progress into T2D, a disease characterized by sustained, uncontrollable high blood sugar. A continual elevation of blood sugar disrupts bodily organ functions, and may eventually lead to severe complications or death. Currently, diabetes affects 2.7 million Canadians and is a leading underlying cause of cardiovascular disease, kidney disease, blindness and neuropathy. Despite its high prevalence, current therapies for T2D remain inadequate.
Recent findings suggest that IR and T2D may contain strong immune components. Researchers, some from our very own lab, have provided evidence indicating that the body’s immune system, which normally protects against infections and cancer, may be unintentionally promoting the disease. As normal mice are placed on a high fat diet, they become obese and develop a disease that is similar to type 2 diabetes in humans. Fatty tissues of these mice contain a high amount of immune cells, including macrophages, neutrophils, T and B cells that produce inflammation. Interestingly, by neutralizing this inflammation, the metabolic disease is relieved. Thus, diabetes induced by a high fat diet is caused, at least partly, by an abnormal immune response, or inflammation in the body’s fat. These discoveries have redefined the way the medical community perceives insulin resistant T2D—as an immune disease, in addition to its metabolic component, providing new insights to the treatment of the condition by modulation of the immune system.
Our lab's previous work on T and B cells in fat was recently featured in hundreds of news media as one of the preeminent new findings in medicine. The objective of our current study is to build on this work, and further elucidate the harmful role the immune system plays in T2D. We will be investigating how another immune cell, the neutrophil, functions to start the entire process of inflammation in diabetes. When neutrophils encounter bacteria, they release web-like structures called neutrophil extracellular traps (NETs), made up of proteins and DNA. These NETs kill bacteria, but if they are not cleared from the body, the rest of the immune system recognizes them as foreign, leading to unwanted inflammation. Notably, this has been shown to drive other diseases, such as lupus and type 1 diabetes, and here we aim to show that a similar process occurs in T2D. We have planned out a series of experiments using sophisticated scientific techniques and technology to test this hypothesis. Our current data indicate that there is indeed increased production of NETs within the fat of obese mice, and we will now identify how NETs promote high blood sugar in mice by studying inflammation in fat. We also aim to determine which immune cells NETs target, and how those immune cells promote IR and diabetes. Ultimately, the results of this study could allow for us to identify new and effective ways to diagnose and treat diabetes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311885
Name
Ghazarian Magar D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of Neutrophil Extracellular Traps and their Toll-like Receptors in Insulin Resistance and Type II Diabetes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diabetes; Inflammation; Insulin Resistance; Macrophages; Neutrophil Extracellular Traps; Obesity; Plasmacytoid Dendritic Cells; Pro-Inflammatory Cytokines; Targeted Immunotherapy; Toll-Like Receptors
Abstract
Obesity and type 2 diabetes (T2D) are major global health concerns. Over 25 percent of Canadians are obese, and these individuals are at high risks for developing insulin resistance (IR) and T2D. Insulin resistance is a condition where the body’s cells fail to respond to the effects of insulin, a hormone responsible for reducing blood sugar levels. Over time, the condition can progress into T2D, a disease characterized by sustained, uncontrollable high blood sugar. A continual elevation of blood sugar disrupts bodily organ functions, and may eventually lead to severe complications or death. Currently, diabetes affects 2.7 million Canadians and is a leading underlying cause of cardiovascular disease, kidney disease, blindness and neuropathy. Despite its high prevalence, current therapies for T2D remain inadequate.
Recent findings suggest that IR and T2D may contain strong immune components. Researchers, some from our very own lab, have provided evidence indicating that the body’s immune system, which normally protects against infections and cancer, may be unintentionally promoting the disease. As normal mice are placed on a high fat diet, they become obese and develop a disease that is similar to type 2 diabetes in humans. Fatty tissues of these mice contain a high amount of immune cells, including macrophages, neutrophils, T and B cells that produce inflammation. Interestingly, by neutralizing this inflammation, the metabolic disease is relieved. Thus, diabetes induced by a high fat diet is caused, at least partly, by an abnormal immune response, or inflammation in the body’s fat. These discoveries have redefined the way the medical community perceives insulin resistant T2D—as an immune disease, in addition to its metabolic component, providing new insights to the treatment of the condition by modulation of the immune system.
Our lab's previous work on T and B cells in fat was recently featured in hundreds of news media as one of the preeminent new findings in medicine. The objective of our current study is to build on this work, and further elucidate the harmful role the immune system plays in T2D. We will be investigating how another immune cell, the neutrophil, functions to start the entire process of inflammation in diabetes. When neutrophils encounter bacteria, they release web-like structures called neutrophil extracellular traps (NETs), made up of proteins and DNA. These NETs kill bacteria, but if they are not cleared from the body, the rest of the immune system recognizes them as foreign, leading to unwanted inflammation. Notably, this has been shown to drive other diseases, such as lupus and type 1 diabetes, and here we aim to show that a similar process occurs in T2D. We have planned out a series of experiments using sophisticated scientific techniques and technology to test this hypothesis. Our current data indicate that there is indeed increased production of NETs within the fat of obese mice, and we will now identify how NETs promote high blood sugar in mice by studying inflammation in fat. We also aim to determine which immune cells NETs target, and how those immune cells promote IR and diabetes. Ultimately, the results of this study could allow for us to identify new and effective ways to diagnose and treat diabetes.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ghazarian, Magar D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~